American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

UroGen Pharma Ltd. (URGN)

$34.49 -1.88% NASDAQ: URGN · 15-min delayed

RA'ANANA, L3
Public · NASDAQ: URGN
291 employees

Visit website Follow

$2.0BMarket cap

$109.8MRevenue · FY2025

-$153.5MNet income

291Employees

URGNNASDAQ

2017IPO

About UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: URGN
Employees: 291
IPO date: May 4, 2017
Headquarters: 9 HA'TA'ASIYA ST
RA'ANANA, L3 4365007
Phone: 972 9 770 7601
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: URGN Nasdaq
SEC CIK: 1668243
LEI: 549300C0YCX7CG2G5D50
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show UroGen Pharma Ltd.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/urogen-pharma-ltd/"><img src="https://americancompanies.com/badge/urogen-pharma-ltd.svg" alt="UroGen Pharma Ltd. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow UroGen Pharma Ltd. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $109.8M
Net income: -$153.5M
Total assets: $200.5M
Market cap: $2.0B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: URGN

$34.49 -1.88%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$16.42 $50.29

52-week range

Market cap: $2.0B
Shares outstanding: 57.9M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: May 4, 2017

UroGen Pharma Ltd. (URGN) Stock Price

Reported a net loss of $153.5M in FY2025.
Trading 31% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review UroGen Pharma Ltd..

Write a review

Newsroom

News about UroGen Pharma Ltd.

Here's Why You Should Add URGN Stock to Your Portfolio Now Zacks Investment Research · 2026-09-30 · positive Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus Zacks Investment Research · 2026-09-08 · positive UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. · 2026-09-04 · positive UroGen's Chief Medical Officer Sold $400,000 in Stock After a 191% Run The Motley Fool · 2026-07-12 · positive Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares? The Motley Fool · 2026-06-14 · negative UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence GlobeNewswire Inc. · 2026-03-13 · positive

News & sentiment via Polygon.io

FAQ

UroGen Pharma Ltd.: frequently asked questions

Is UroGen Pharma Ltd. an American company?

UroGen Pharma Ltd. is a US-based company headquartered in Ra'Anana, L3, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is UroGen Pharma Ltd. headquartered?

UroGen Pharma Ltd. is headquartered in Ra'Anana, L3, United States.

Is UroGen Pharma Ltd. publicly traded?

Yes — UroGen Pharma Ltd. is a publicly traded company. Its stock trades under the ticker symbol URGN on the NASDAQ.

What does UroGen Pharma Ltd. do?

UroGen Pharma Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore